Abound Wealth Management Edwards Lifesciences Corp Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Abound Wealth Management holds 104 shares of EW stock, worth $7,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104
Previous 116
10.34%
Holding current value
$7,495
Previous $10.7 Million
35.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EW
# of Institutions
1,349Shares Held
456MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.51 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.67 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.27 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.89 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$974 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...